Soleus Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-226,218
Closed -$12.5M 100
2025
Q1
$12.5M Buy
+226,218
New +$12.2M 0.9% 32
2024
Q4
Sell
-612,000
Closed -$35.3M 105
2024
Q3
$35.3M Buy
612,000
+549,500
+879% +$29.7M 2.73% 10
2024
Q2
$3.03M Buy
+62,500
New +$3.01M 0.27% 72

Other funds holding SNY

Soleus Capital Management's SNY Position: Q2 2025 in Review

Soleus Capital Management sold out of Sanofi (SNY) in Q2 2025, closing a stake of 226,218 shares — an estimated $12.5M sold.

Soleus Capital Management first reported a position in SNY in Q2 2024 and held it in 3 quarters. The position peaked at $35.3M in Q3 2024. 729 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Soleus Capital Management reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Soleus Capital Management sold 226,218 Sanofi shares in Q2 2025, an estimated $12.5M.
  • Soleus Capital Management first reported a position in Sanofi in Q2 2024 and held it in 3 quarters.
  • Soleus Capital Management's Sanofi position peaked at $35.3M in Q3 2024.
  • 729 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Soleus Capital Management's 13F filing for Q2 2025, filed 15 Aug 2025.